An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer. Tofacitinib, taken orally, could serve as an alternative approach to treating moderate to severe patients who did not respond to one…
US pharmaceutical giant Pfizer on Thursday began long-awaited compensation payments to families over a 1996 drug trial blamed for the deaths of 11 children and disabilities in dozens of others. But even as the compensation process began, the company faced further criticism since only four families were paid in the…